Quality Matters

OCTOBER 24, 2023

The event spotlighted perspectives from manufacturers, regulators, healthcare providers, legislators, academia and patients, and issued a call to action for stakeholders to come together to advance needed reforms. Generics make up the lion’s share of aggregate shortages at 82%, and a majority are sterile injectables at 58%, he said.

Chemotherapy 64

Chemotherapy Hospitals 64

pharmaphorum

OCTOBER 1, 2021

This issue assesses European pharma’s approach to strategic communications, the future of pharma commercialisation, communications gaps with patients and, with the pandemic continuing to cast a long shadow over healthcare, how to maximise the effectiveness of HCP engagement. Company Spotlight: The Method.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

PharmaState Academy

JANUARY 23, 2024

Bangladesh’s Pharmaceutical Industry: Achievements and Future Prospects with Sadman Hassan : Sadman Hassan, Director, Aristopharma Ltd. Customer Centricity, Future Transformation, and Market Landscape Discussions: Mr. Tanbir highlighted the importance of customer-centricity in the pharmaceutical industry.

Biosimilars 52

Biosimilars Communication 52

Quality Matters

MAY 18, 2023

Coburn spotlighted four related objectives: Increasing manufacturing flexibility while maintaining quality and accountability; improving supply chain visibility; increasing redundancies in suppliers and decreasing supply chain length; and modernizing and optimizing stockpiling. Coukell observed. “At

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing 52

Quality Matters

JUNE 8, 2023

FDA and Center for Research on Complex Generics, as well as at the 8th Global Pharmaceutical Quality Summit hosted by the Indian Pharmaceutical Alliance (IPA) in Mumbai – both taking place this month. Recent recalls have put the issue back in the spotlight. These efforts dovetail with those of the U.S.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 5, 2021

As we proceed through 2021, the spotlight on antitrust activity in the life sciences industry shines brighter than ever. Recent Criminal Generic Price Fixing Cases and How They May Change the Outlook for Competition in the Industry. For several years, state and federal antitrust enforcers in the U.S.

52

52

PharmaShots

APRIL 26, 2023

While the efficacy and safety profile of Dupixent is well-established for atopic dermatitis more broadly, these positive results are the first demonstrating the impact on specific and heavily used areas of the body.”

Biosimilars 56

Biosimilars Dosage 56